Myriad Genetics Inc (NAS:MYGN)
$ 26.835 0.445 (1.69%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Myriad Genetics Inc Investor Day Transcript

Sep 19, 2023 / 05:00PM GMT
Release Date Price: $17.36 (+1.94%)
Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director

So we're really excited to have you all here today, and most importantly, to talk about the progress we've made and to talk about the course of the future. I was remiss, I need to remind everyone that we will be making certain forward-looking statements. Make sure you look at our website in the event (inaudible) changes.

So Ted, I'm not seeing the prompts here, but I'm going to keep going anyway. Here we go. All right. A little technical difficulty to start. Thank you. Again, welcome, everyone. Really excited to have you guys here, both in-person and virtual. We have a lot to cover today. And I think most importantly, you'll hear from our team about the excitement about the progress that we've made and the future that we've laid before us.

Always start, it's important for investors and everyone to understand that we're a really mission-driven organization here. Our folks get up every morning thinking about the patients that we serve, the providers that we enable to provide care and the role that we think genomics and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot